APSR2026-184

 
Late-Breaking
Submitted
Poster Presentation
YIA02-004
AP16-007
P123
https://storage.unitedwebnetwork.com/files/1285/1198377-46903-APSR-184_440972.pptx
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1198377-46904-APSR-184_439627.pdf
Format: PDF Only
15. Pulmonary Circulation
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Sugeesha Wickramasinghe * Royal Preston Hospital Respiratory Medicine Preston United Kingdom
Sean Connell - Royal Preston hOSPITAL Respiratory Medicine Preston United Kingdom
Sarah Macrae - Royal Preston hOSPITAL Respiratory Medicine Preston United Kingdom
Yussef Haider - Royal Preston hOSPITAL Respiratory Medicine Preston United Kingdom
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Sugeesha
Wickramasinghe
sugeesha@gmail.com
+447459038508
31-40
Sri Lanka
Case Report
Hereditary haemorrhagic telangiectasia complicated with incidental pulmonary embolism, portal vein thrombosis and life threatening epistaxis - A diagnostic conundrum
Maximum 25 words
Abstract Content
 
 
 
 
Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disorder characterised by mucocutaneous telangiectasia and arteriovenous malformations, predisposing patients to significant bleeding. Paradoxically, HHT is also associated with an increased risk of venous thromboembolism, making anticoagulation decisions complex and potentially life-threatening. We describe a challenging case of recurrent thromboembolism in a patient with HHT.
A 53-year-old woman with established HHT and recurrent severe epistaxis, previously treated with laser therapy and embolisation, was referred following incidental detection of a right upper lobe segmental pulmonary embolism (PE) on CT pulmonary angiography (CTPA). Imaging was initially performed after she developed an ischaemic stroke post-embolisation to exclude pulmonary arteriovenous malformation; no AVM was identified. Given the segmental clot burden and high bleeding risk, conservative management was adopted. Repeat CTPA demonstrated new bilateral basal segmental PEs. Concurrently, she presented with abdominal pain, and CT imaging confirmed portal vein thrombosis (PVT). Therapeutic enoxaparin was initiated but complicated by severe epistaxis requiring transfusion, necessitating cessation of anticoagulation. Her history was notable for rheumatoid arthritis, Raynaud’s phenomenon, recurrent miscarriages (7 and 12 weeks) and a stillbirth at 24 weeks, raising suspicion of an underlying prothrombotic disorder. Due to thrombus location and extent, inferior vena cava filter insertion was not feasible. Multidisciplinary discussions involving hepatobiliary, thromboembolism, haematology, and interventional radiology teams concluded that conservative management was most appropriate. Anaemia and iron deficiency were optimised, and thrombophilia screening was arranged.
This case highlights the therapeutic dilemma of balancing bleeding and thrombosis risks in HHT. Management requires careful individualised risk–benefit assessment and multidisciplinary collaboration to guide complex anticoagulation decisions.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
HHT, Pulmoanry embolism, Bleeding, portal vein thrombosis
maximum 3 keywords and no abbreviations, separated by commas
 
260